Tandem Diabetes Care Inc (TNDM)
R&D Expenses
$186.91M
TTM · Period ending: · USD
TNDM R&D Expenses
Latest reported$186.91Mperiod ending
Latest reported$186.91Mperiod ending
TNDM TTM R&D Expenses ($11.08M → $186.91M)
TTM R&D Expenses
High-resolution chart · PNG
TNDM r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 186,914,000 | |
| 188,102,000 | |
| 267,499,000 | |
| 273,633,000 | |
| 276,857,000 | |
| 278,065,000 | |
| 198,877,000 | |
| 189,281,000 | |
| 180,144,000 | |
| 173,751,000 | |
| 248,417,000 | |
| 241,421,000 | |
| 267,265,000 | |
| 257,903,000 | |
| 170,153,000 | |
| 164,037,000 | |
| 120,325,000 | |
| 107,253,000 | |
| 92,054,000 | |
| 79,938,000 | |
| 71,930,000 | |
| 67,418,000 | |
| 63,574,000 | |
| 58,765,000 | |
| 54,709,000 | |
| 49,926,000 | |
| 45,198,000 | |
| 41,428,000 | |
| 37,389,000 | |
| 32,641,000 | |
| 29,227,000 | |
| 26,181,000 | |
| 23,096,000 | |
| 21,506,000 | |
| 20,661,000 | |
| 19,254,000 | |
| 20,494,000 | |
| 19,770,000 | |
| 18,809,000 | |
| 18,586,000 | |
| 17,525,000 | |
| 17,256,000 | |
| 16,950,000 | |
| 16,751,000 | |
| 16,166,004 | |
| 15,991,004 | |
| 15,791,324 | |
| 15,215,706 | |
| 13,359,282 | |
| 12,420,043 | |
| 11,079,200 | |
| 9,722,097 | |
| 9,180,385 |